Page last updated: 2024-11-05

trihexyphenidyl and Epilepsy, Absence

trihexyphenidyl has been researched along with Epilepsy, Absence in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Epilepsy, Absence: A seizure disorder usually occurring in childhood characterized by rhythmic electrical brain discharges of generalized onset. Clinical features include a sudden cessation of ongoing activity usually without loss of postural tone. Rhythmic blinking of the eyelids or lip smacking frequently accompanies the SEIZURES. The usual duration is 5-10 seconds, and multiple episodes may occur daily. Juvenile absence epilepsy is characterized by the juvenile onset of absence seizures and an increased incidence of myoclonus and tonic-clonic seizures. (Menkes, Textbook of Child Neurology, 5th ed, p736)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sharma, A1
Sinha, S1
Narang, A1
Chouhan, DK1
Gupta, S1

Other Studies

1 other study available for trihexyphenidyl and Epilepsy, Absence

ArticleYear
Waddling Gait: A complication of valproate therapy and a thought beyond vitamin D deficiency.
    Sultan Qaboos University medical journal, 2020, Volume: 20, Issue:1

    Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Drug Therapy, Combination; Epilepsy, Absence; Fem

2020